Article

Psychiatric Genome-wide Association Study Enrichment Shows Promise for Future Psychopharmaceutical Discoveries

2023-12-05

Abstract excerpt

Innovation in psychiatric therapeutics has stagnated on a handful of known mechanisms. Psychiatric genome-wide association studies (GWASs) have begun to identify hundreds of genome-wide significant (GWS) loci and characterize complex polygenic architectures. These data have rapidly advanced our understanding of disease etiology but their ability to inform clinical treatment in psychiatry remains largely unexplored...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: bdebd46c-1658-5706-a6f5-5e1d407ae65d
DOI: 10.1101/2023.12.05.23299434

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Psychiatric Genome-wide Association Study Enrichment Shows Promise for Future Psychopharmaceutical DiscoveriesDOI 10.1101/2023.12.05.23299434Read

Psychiatric genome-wide association study enrichment shows promise for future psychopharmaceutical discoveriesSemantic proximity Read

Translating genome-wide association findings into new therapeutics for psychiatry.Semantic proximity Read

Leveraging the genetics of psychiatric disorders to prioritize potential drug targets and compounds.Semantic proximity Read

Leveraging the Genetics of Psychiatric Disorders to Prioritize Potential Drug Targets and CompoundsSemantic proximity Read

Linking GWAS to pharmacological treatments for psychiatric disordersSemantic proximity Read

Delineating significant genome-wide associations of variants with antipsychotic and antidepressant treatment response: implications for clinical pharmacogenomics.Semantic proximity Read

Identifying drug targets for schizophrenia through gene prioritization.Semantic proximity Read

Mendelian Randomization Using the Druggable Genome Reveals Genetically Supported Drug Targets for Psychiatric Disorders.Semantic proximity Read

Genomewide association studies: history, rationale, and prospects for psychiatric disorders.Semantic proximity Read

Genome-wide association studies of schizophrenia: does bigger lead to better results?Semantic proximity Read

Identifying drug targets for schizophrenia through gene prioritizationSemantic proximity Read

When GWAS meets the Connectivity Map: drug repositioning for seven psychiatric disordersSemantic proximity Read